These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 27870240)

  • 1. Analyzing Promiscuity at the Level of Active Compounds and Targets.
    Bajorath J
    Mol Inform; 2016 Dec; 35(11-12):583-587. PubMed ID: 27870240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Data structures for computational compound promiscuity analysis and exemplary applications to inhibitors of the human kinome.
    Miljković F; Bajorath J
    J Comput Aided Mol Des; 2020 Jan; 34(1):1-10. PubMed ID: 31792884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity profile relationships between structurally similar promiscuous compounds.
    Hu Y; Bajorath J
    Eur J Med Chem; 2013 Nov; 69():393-8. PubMed ID: 24077530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancing Molecular Promiscuity Evaluation Through Assay Profiles.
    Avram S; Curpan R; Bora A; Neanu C; Halip L
    Pharm Res; 2018 Oct; 35(11):240. PubMed ID: 30338400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic computational identification of promiscuity cliff pathways formed by inhibitors of the human kinome.
    Miljković F; Vogt M; Bajorath J
    J Comput Aided Mol Des; 2019 Jun; 33(6):559-572. PubMed ID: 30915709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High Impact: The Role of Promiscuous Binding Sites in Polypharmacology.
    Cerisier N; Petitjean M; Regad L; Bayard Q; Réau M; Badel A; Camproux AC
    Molecules; 2019 Jul; 24(14):. PubMed ID: 31295958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of orthologous target pairs with shared active compounds and comparison of organism-specific activity patterns.
    Dimova D; Stumpfe D; Bajorath J
    Chem Biol Drug Des; 2015 Nov; 86(5):1105-14. PubMed ID: 25931211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationalizing Promiscuity Cliffs.
    Dimova D; Bajorath J
    ChemMedChem; 2018 Mar; 13(6):490-494. PubMed ID: 29024534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determining the Degree of Promiscuity of Extensively Assayed Compounds.
    Jasial S; Hu Y; Bajorath J
    PLoS One; 2016; 11(4):e0153873. PubMed ID: 27082988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantifying the tendency of therapeutic target proteins to bind promiscuous or selective compounds.
    Hu Y; Bajorath J
    PLoS One; 2015; 10(5):e0126838. PubMed ID: 26000736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What is the likelihood of an active compound to be promiscuous? Systematic assessment of compound promiscuity on the basis of PubChem confirmatory bioassay data.
    Hu Y; Bajorath J
    AAPS J; 2013 Jul; 15(3):808-15. PubMed ID: 23605807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promiscuity progression of bioactive compounds over time.
    Hu Y; Jasial S; Bajorath J
    F1000Res; 2015; 4(Chem Inf Sci):118. PubMed ID: 26064479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compound promiscuity: what can we learn from current data?
    Hu Y; Bajorath J
    Drug Discov Today; 2013 Jul; 18(13-14):644-50. PubMed ID: 23524195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological Activity Profiles of Multitarget Ligands from X-ray Structures.
    Feldmann C; Bajorath J
    Molecules; 2020 Feb; 25(4):. PubMed ID: 32059498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Entering the 'big data' era in medicinal chemistry: molecular promiscuity analysis revisited.
    Hu Y; Bajorath J
    Future Sci OA; 2017 Jun; 3(2):FSO179. PubMed ID: 28670471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of Promiscuity Cliffs Using Machine Learning.
    Blaschke T; Feldmann C; Bajorath J
    Mol Inform; 2021 Jan; 40(1):e2000196. PubMed ID: 32881355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matched molecular pair analysis of small molecule microarray data identifies promiscuity cliffs and reveals molecular origins of extreme compound promiscuity.
    Dimova D; Hu Y; Bajorath J
    J Med Chem; 2012 Nov; 55(22):10220-8. PubMed ID: 23050678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping Biological Activities to Different Types of Molecular Scaffolds: Exemplary Application to Protein Kinase Inhibitors.
    Dimova D; Bajorath J
    Methods Mol Biol; 2018; 1825():327-337. PubMed ID: 30334211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping of inhibitors and activity data to the human kinome and exploring promiscuity from a ligand and target perspective.
    Hu Y; Kunimoto R; Bajorath J
    Chem Biol Drug Des; 2017 Jun; 89(6):834-845. PubMed ID: 27933727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polypharmacology: The science of multi-targeting molecules.
    Kabir A; Muth A
    Pharmacol Res; 2022 Feb; 176():106055. PubMed ID: 34990865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.